Cancer: Drugs

(asked on 8th January 2021) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the feasibility of outcome-based payment for cancer medicines.


Answered by
Jo Churchill Portrait
Jo Churchill
Minister of State (Department for Work and Pensions)
This question was answered on 26th January 2021

Outcome-based payment arrangements are one type of commercial flexibility that NHS England and NHS Improvement can choose to utilise when negotiating with pharmaceutical companies on new innovative cancer and non-cancer treatments.

The final NHS Commercial Framework for Medicines, which will be published shortly, outlines how commercial flexibilities can be negotiated to accommodate the unique circumstances of each topic the National Institute for Health and Care Excellence is appraising, on a case-by-case basis.

Reticulating Splines